Quick Ratios
Quarterly Results
Profit & Loss
Balance Sheet
Cash Flow
Ratios
Mkt Cap
Market Capitalization
₹62Cr
Rev Gr TTM
Revenue Growth TTM
-4.70%
Peer Comparison
Compare up to 10 companies side by side across valuation, profitability, and growth.

UNIVSTAR
VS
| Quarter | Mar 2023 | Jun 2023 | Sep 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|
|
Growth YoY Revenue Growth YoY% | 5.9 | 0.0 | 0.4 | 3.9 | 4.4 | -2.0 | -24.1 | 1.8 | -4.8 | -8.9 | 6.8 | -8.5 |
| 134 | 129 | 116 | 124 | 138 | 128 | 96 | 118 | 130 | 120 | 93 | 108 |
Operating Profit Operating ProfitCr |
| 3.8 | 4.9 | 3.4 | 1.5 | 5.1 | 4.0 | -5.7 | 8.2 | 5.6 | 1.3 | 4.7 | 8.3 |
Other Income Other IncomeCr | 1 | 0 | 1 | 0 | 2 | 0 | 0 | 0 | 1 | 0 | 1 | 0 |
Interest Expense Interest ExpenseCr | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 3 | 2 | 2 | 2 |
Depreciation DepreciationCr | 1 | 1 | 1 | 2 | 1 | 1 | 2 | 2 | 2 | 2 | 2 | 2 |
| 3 | 4 | 1 | -1 | 6 | 2 | -9 | 7 | 4 | -2 | 1 | 6 |
| 1 | 0 | 0 | 0 | 1 | 1 | 0 | 0 | 1 | 0 | 0 | 1 |
|
Growth YoY PAT Growth YoY% | -46.5 | 158.4 | 406.7 | -158.7 | 85.1 | -66.0 | -1,181.6 | 816.3 | -34.4 | -271.9 | 109.3 | -25.4 |
| 1.7 | 3.2 | 0.6 | -0.8 | 3.1 | 1.1 | -9.0 | 5.5 | 2.1 | -2.1 | 0.8 | 4.5 |
| 5.8 | 10.2 | 1.8 | -2.3 | 10.7 | 3.5 | -19.6 | 16.7 | 7.0 | -6.0 | 1.8 | 12.5 |
| Financial Year | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|
|
| 6.2 | -15.5 | 29.6 | -7.6 | 41.0 | -5.4 | 12.3 | 54.0 | 13.0 | 2.2 | -6.9 | -3.4 |
| 190 | 163 | 215 | 190 | 268 | 254 | 279 | 431 | 498 | 507 | 473 | 451 |
Operating Profit Operating ProfitCr |
| 3.0 | 1.3 | -0.3 | 3.8 | 4.1 | 3.8 | 5.9 | 5.6 | 3.4 | 3.8 | 3.7 | 5.0 |
Other Income Other IncomeCr | 2 | 3 | 3 | 1 | 2 | 2 | 1 | 2 | 3 | 3 | 2 | 2 |
Interest Expense Interest ExpenseCr | 5 | 4 | 4 | 4 | 6 | 7 | 7 | 8 | 7 | 8 | 9 | 9 |
Depreciation DepreciationCr | 5 | 4 | 4 | 4 | 4 | 5 | 4 | 4 | 5 | 6 | 6 | 7 |
| -2 | -4 | -6 | 1 | 3 | 0 | 7 | 16 | 8 | 9 | 4 | 9 |
| -1 | -2 | -2 | 1 | 2 | 0 | 1 | 4 | 2 | 2 | 1 | 2 |
|
| -129.0 | -55.1 | -148.8 | 105.9 | 468.8 | -53.3 | 862.2 | 79.8 | -48.4 | 18.4 | -54.0 | 100.2 |
| -0.6 | -1.0 | -2.0 | 0.1 | 0.5 | 0.3 | 2.1 | 2.5 | 1.1 | 1.3 | 0.7 | 1.4 |
| -2.6 | -4.0 | -10.0 | 0.6 | 3.4 | 1.6 | 15.1 | 27.2 | 14.1 | 16.6 | 7.7 | 15.3 |
| Financial Year | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|
Equity Capital Equity CapitalCr | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 |
| 6 | 4 | 9 | 9 | 32 | 34 | 37 | 48 | 54 | 62 | 66 | 64 |
Current Liabilities Current LiabilitiesCr | 51 | 60 | 73 | 58 | 72 | 82 | 80 | 83 | 101 | 116 | 116 | 112 |
Non Current Liabilities Non Current LiabilitiesCr | 29 | 25 | 20 | 33 | 40 | 37 | 55 | 52 | 45 | 41 | 40 | 36 |
Total Liabilities Total LiabilitiesCr |
Current Assets Current AssetsCr | 42 | 48 | 50 | 51 | 58 | 70 | 83 | 81 | 94 | 110 | 99 | 93 |
Non Current Assets Non Current AssetsCr | 48 | 45 | 55 | 53 | 91 | 87 | 92 | 106 | 110 | 114 | 126 | 123 |
Total Assets Total AssetsCr |
| Financial Year | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|
Operating Cash Flow Operating Cash FlowCr | 17 | -4 | 13 | -8 | 11 | 11 | 11 | 34 | -1 | 19 | 23 |
Investing Cash Flow Investing Cash FlowCr | -5 | -2 | -2 | -1 | -18 | -1 | -9 | -18 | -9 | -9 | -18 |
Financing Cash Flow Financing Cash FlowCr | -9 | 3 | -11 | 8 | 10 | -11 | 1 | -18 | 14 | -10 | -5 |
|
Free Cash Flow Free Cash FlowCr | 12 | -6 | 11 | -9 | -8 | 10 | 2 | 16 | -9 | 10 | 4 |
| -1,514.2 | 240.9 | -318.6 | -3,033.0 | 789.0 | 1,601.2 | 168.2 | 300.9 | -14.7 | 272.1 | 703.1 |
CFO To EBITDA CFO To EBITDA% | 284.9 | -190.0 | -1,962.6 | -100.7 | 97.5 | 106.4 | 61.1 | 134.7 | -5.0 | 94.5 | 123.0 |
| Financial Year | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|
Valuation Ratios Valuation Ratios |
Market Cap Market CapitalizationCr | 12 | 0 | 12 | 12 | 20 | 8 | 29 | 58 | 45 | 76 | 65 |
Price To Earnings Price To Earnings | 0.0 | 0.0 | 0.0 | 47.5 | 14.0 | 12.4 | 4.5 | 5.1 | 7.7 | 10.9 | 20.4 |
Price To Sales Price To Sales | 0.1 | 0.0 | 0.1 | 0.1 | 0.1 | 0.0 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 |
Price To Book Price To Book | 1.2 | 0.0 | 0.9 | 0.9 | 0.5 | 0.2 | 0.7 | 1.1 | 0.8 | 1.1 | 0.9 |
| 5.8 | 13.6 | -50.4 | 6.2 | 5.7 | 5.0 | 4.5 | 3.9 | 6.0 | 6.6 | 7.0 |
Profitability Ratios Profitability Ratios |
| 16.7 | 15.2 | 12.2 | 16.6 | 16.8 | 16.9 | 23.3 | 21.6 | 17.8 | 19.6 | 19.4 |
| 3.0 | 1.3 | -0.3 | 3.8 | 4.1 | 3.8 | 5.9 | 5.6 | 3.4 | 3.8 | 3.7 |
| -0.6 | -1.0 | -2.0 | 0.1 | 0.5 | 0.3 | 2.1 | 2.5 | 1.1 | 1.3 | 0.7 |
| 8.4 | 1.0 | -5.5 | 9.0 | 10.7 | 8.8 | 15.0 | 24.1 | 12.2 | 13.3 | 9.8 |
| -10.8 | -20.0 | -32.3 | 1.8 | 3.9 | 1.7 | 15.5 | 21.9 | 10.1 | 10.5 | 4.6 |
| -1.2 | -1.8 | -4.0 | 0.2 | 0.9 | 0.4 | 3.6 | 6.1 | 2.9 | 3.1 | 1.4 |
Operational Ratios Operational Ratios |
Solvency Ratios Solvency Ratios |
Liquidity Ratios Liquidity Ratios |
Universal Starch Chem Allied Limited is a premier Indian maize refiner with a legacy spanning over **52 years**. The company operates a vertically integrated manufacturing model, transforming raw maize into a sophisticated portfolio of starches, sweeteners, and industrial derivatives. Serving as a critical supplier to the **Pharmaceutical, Food, Textile, and Paper** industries, the company is currently transitioning from a traditional commodity processor to a high-value derivatives manufacturer with an expanding global footprint.
---
### **Core Manufacturing Infrastructure & Vertical Integration**
The company’s operations are centralized at its primary integrated facility in **Dhule District, Maharashtra**, which has undergone significant scaling since inception.
* **Processing Capacity:** The facility has expanded from an initial **60 MTS** to a current refining capacity of **750 MTS per day**.
* **Strategic Asset Acquisition:** Under the **SARFAESI Act**, the company recently acquired land, buildings, and machinery for **₹17.18 Crores**. This strategic move is designed to facilitate the production of high-value derivatives and expand the existing product line.
* **Sustainability & Captive Power:** To mitigate energy costs and environmental impact, the company operates:
* A **Co-Generation Power Plant** utilizing bio-gas from an **Effluent Treatment Plant**.
* A **Wind Mill** located at **Brahmanwel** for renewable energy generation.
* A **Biomethanation Project** and a **Fly Ash Brick Making Project** for waste valorization.
* **Quality & Compliance:** The facility holds a **GMP license** from the **FDA (MS)**. Recent upgrades include a new **Air Handling Unit (AHU)** at the Microbiology Laboratory to ensure strict adherence to mandatory FDA hygiene and safety standards.
---
### **Diversified Product Portfolio & Market Applications**
The company reports under a single business segment (**Maize Products**) as per **Ind AS-108**, yet maintains a highly diversified output categorized by industrial application:
| Category | Key Products | Primary Industrial Use |
| :--- | :--- | :--- |
| **Primary Starches** | Maize Starch Powder, Modified Starch | Food thickening, Paper coating, Textile sizing |
| **Specialized Derivatives** | **White Dextrin**, **Pregelatinized Starch** | Adhesives, Industrial binders |
| **Sweeteners & Syrups** | **Liquid Glucose**, **Dextrose Syrup**, **Dextrose Monohydrate**, **Dextrose Anhydrous** | Confectionery, Pharmaceutical excipients, Beverages |
| **Nutritional By-Products** | **Maize Gluten**, Maize Germ, Maize Husk | High-protein animal and poultry feed |
The company has been recognized as a **'Best Vendor'** by the **OPPI** for its role as a reliable excipient supplier to the pharmaceutical sector.
---
### **Financial Performance & Growth Metrics**
While the company has demonstrated long-term resilience, recent fiscal cycles reflect the volatility of the agricultural commodity market.
| Metric (Rs. in Lacs) | FY 2024-25 | FY 2023-24 | FY 2022-23 |
| :--- | :--- | :--- | :--- |
| **Total Sales & Other Income** | **49,089.13** | **53,023.00** | **51,872.00** |
| **Profit Before Depreciation** | **1,055.70** | **1,501.00** | **1,319.00** |
| **Net Profit Before Tax (PBT)** | **427.28** | **922.00** | **810.00** |
**Performance Analysis:**
* **Revenue Trends:** Following a peak in FY 2023-24, sales contracted by **7.14%** in the most recent period due to adverse market conditions.
* **Profitability:** Operating profit and PBT saw a decline in the latest cycle, attributed to volatile raw material pricing and shifting demand.
* **Incentives:** The company is eligible for a **₹73.45 crore incentive** under the **Package Scheme of Incentive - 2007**, which provides a steady cash inflow of **₹7.34 crore per year** over a **10-year** period.
---
### **Strategic Roadmap: Expansion & R&D**
The company’s growth strategy is centered on **organic expansion** and moving up the value chain.
* **Export Market Penetration:** A primary strategic pillar is increasing the share of exports, with a specific focus on the **Middle East** market to diversify revenue streams.
* **R&D Focus:** The dedicated **Research & Development Department** is tasked with upgrading production technology for **Value-Added Products** and refining **Standard Operating Procedures (SOP)** to drive energy savings and productivity.
* **Agricultural Outlook:** Management anticipates a **30% increase** in local maize cultivation over the next two years as farmers shift from competing crops, which is expected to stabilize raw material costs.
* **Cost Optimization:** Implementation of stringent cost-cutting measures is underway to protect margins against inflationary pressures.
---
### **Governance, Leadership & Capital Structure**
The company is led by the promoter family with a restructured board to oversee its next growth phase.
* **Key Leadership:**
* **Chairman & MD:** Mr. Jitendrasinh J. Rawal (Term: **3 years** from Oct 2024).
* **Joint MD:** Mr. Jaykumar J. Rawal (Term: **3 years** from Aug 2023).
* **CFO:** Mr. Jivan Mali (Appointed Nov 2024).
* **Board Composition:** **10 members**, including **5 Independent Directors**, ensuring balanced oversight through Audit and Stakeholder committees.
* **Financing Strategy:** To avoid high institutional interest rates, the company secured an unsecured loan of **₹4.25 crores** from the Managing Director. Shareholders have approved a resolution allowing the **conversion of these loans into equity** in the event of a repayment default, priced according to **SEBI regulations**.
---
### **Risk Factors & Mitigation**
Investors should note the following risks inherent in the company’s operating environment:
* **Commodity Volatility:** As maize is the primary feedstock, the company is exposed to monsoon risks and price fluctuations. This is reflected in **Inventory Valuation**, where the **Net Realizable Value (NRV)** of finished goods is treated as a **Key Audit Matter** (Finished goods value rose from **₹5.22 crore** in 2024 to **₹11.08 crore** in 2025).
* **Regulatory Compliance:**
* **Labour Codes:** New labour codes introduced in **November 2025** resulted in an exceptional financial impact of **₹5.40 lakhs** due to revised gratuity definitions.
* **SEBI LODR:** The company is working toward **100% Dematerialization** of promoter holdings and addressing a **₹38,000 fine** from the BSE regarding director age-limit resolutions.
* **Legal Constraints:** Domestic growth in certain **modified starch** segments is currently limited by Indian legal restrictions on specific applications.
* **Competitive Landscape:** Rising demand for maize in the **bio-energy** sector is increasing competition for raw materials, necessitating the company's focus on geographic diversification.